Home | Harnessing the power of RNA epigenetics | Cambridge, UK
Storm Therapeutics is a clinical-stage biotechnology company founded in 2015 as a University of Cambridge spin-out, pioneering cellular reprogramming through RNA modifications to treat cancer, inflammation, viruses, and CNS diseases. Its drug discovery platform targets RNA-modifying enzymes to develop small molecule inhibitors, with lead program STC-15 currently in Phase 2 clinical trials for sarcoma.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2026
Dec 2022
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
